Suchergebnisse - "*Antirheumatic Agents"

PubPharm (239)

1

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy : results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

enthalten in: Annals of the rheumatic diseases | 2015

von Mercer, L. | Lunt, M. | Low, A. | +34

2

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients

enthalten in: Arthritis care & research | 2015

von Zhang, J. | Xie, F. | Delzell, E. | +7

3

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis : open label, randomised controlled, non-inferiority trial

enthalten in: BMJ (Clinical research ed.) | 2015

von van Herwaarden, N. | van der Maas, A. | Minten, M. | +6

CommentIn: Ann Intern Med. 2015 Sep 15;163(6):JC9. - PMID 26370036

4

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis : TACIT non-inferiority randomised controlled trial

enthalten in: BMJ (Clinical research ed.) | 2015

von Scott, D. | Ibrahim, F. | Farewell, V. | +9

CommentIn: BMJ. 2015;350:h1192. - PMID 25769296

5

A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C

enthalten in: Annals of the rheumatic diseases | 2015

von Chen, Y. | Chen, H. | Chen, Y. | +5

6

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab

enthalten in: Annals of the rheumatic diseases | 2015

von Neovius, M. | Arkema, E. | Olsson, H. | +5

7

Assessment of income growth in patients with rheumatoid arthritis treated with anti-tumor necrosis factor therapy

enthalten in: Journal of medical economics | 2015

von Bergman, M. | De, G. | Ganguli, A. | +2

8

The comparative safety of tumor necrosis factor inhibitors in rheumatoid arthritis : a meta-analysis update of 44 trials

enthalten in: The American journal of medicine | 2014

von Michaud, T. | Rho, Y. | Shamliyan, T. | +2

CommentIn: Ann Intern Med. 2015 Apr 21;162(8):JC10. - PMID 25894043

9

Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2014

von Fleischmann, R. | Koenig, A. | Szumski, A. | +3

10

Longterm retention rate and risk factor for discontinuation due to insufficient efficacy and adverse events in Japanese patients with rheumatoid arthritis receiving etanercept therapy

enthalten in: The Journal of rheumatology | 2014

von Matsubara, H. | Kojima, T. | Kaneko, A. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]